Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
The Oncologist|April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCCAndrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.Clinical Genitourinary Cancer|December 12, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint InhibitorsNeal S Chawla, Nicolas Sayegh, Nishita Tripathi, et al.Psycho-Oncology|September 2, 2018
Assessment of distress and quality of life in rare cancersCristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, et al.Frontiers in Immunology|January 23, 2024
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapyMarice B Alcantara, Wilson S Tang, Dongfang Wang, et al.Journal for Immunotherapy of Cancer|March 31, 2022
Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapyMegan L Baker, Yu Yamamoto, Mark A Perazella, et al.JCO Oncology Practice|April 10, 2025
Gender Disparities in Citations and Altmetric Attention Score in OncologyRebecca A Campbell, Emma Helstrom, Lauren Chew, et al.Cancer Medicine|July 31, 2021
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern CaliforniaNicholas J Salgia, Alexander Chehrazi-Raffle, JoAnn Hsu, et al.Frontiers in Immunology|August 28, 2023
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profilesAmeish Govindarajan, Nicholas J Salgia, Haiqing Li, et al.Journal of Global Oncology|December 28, 2017
Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in BrazilPaulo G Bergerot, Cristiane D Bergerot, Nazli Dizman, et al.JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.Pageof 7